Abbott has received Emergency Use Authorization (EUA) from the FDA for its BinaxNOW COVID-19 Ag Card rapid test for detection of COVID-19 infection.The company says it will sell this test for $5.Currently, AdvaMed estimates that test manufacturers are shipping about 1 million tests per day. Abbott will ship tens of millions of tests in September, ramping to 50 million tests a month at the beginning of October. Abbott will also launch NAVICA, a complementary mobile app for iPhone and Android devices. |